Sangamo Therapeutics Inc (SGMO)
0.5438
+0.03
(+5.61%)
USD |
NASDAQ |
May 01, 16:00
0.54
0.00 (0.00%)
Pre-Market: 20:00
Sangamo Therapeutics 1 Year Total Returns (Daily): -63.99% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -63.99% |
April 30, 2024 | -64.97% |
April 29, 2024 | -64.47% |
April 26, 2024 | -67.84% |
April 25, 2024 | -68.76% |
April 24, 2024 | -70.12% |
April 23, 2024 | -68.62% |
April 22, 2024 | -69.27% |
April 19, 2024 | -68.72% |
April 18, 2024 | -69.49% |
April 17, 2024 | -70.34% |
April 16, 2024 | -67.15% |
April 15, 2024 | -66.36% |
April 12, 2024 | -60.04% |
April 11, 2024 | -62.66% |
April 10, 2024 | -64.83% |
April 09, 2024 | -65.50% |
April 08, 2024 | -65.31% |
April 05, 2024 | -66.40% |
April 04, 2024 | -64.96% |
April 03, 2024 | -64.74% |
April 02, 2024 | -66.97% |
April 01, 2024 | -65.48% |
March 28, 2024 | -60.58% |
March 27, 2024 | -64.10% |
Date | Value |
---|---|
March 26, 2024 | -63.65% |
March 25, 2024 | -61.34% |
March 22, 2024 | -60.06% |
March 21, 2024 | -48.93% |
March 20, 2024 | -57.72% |
March 19, 2024 | -61.69% |
March 18, 2024 | -57.66% |
March 15, 2024 | -63.89% |
March 14, 2024 | -63.89% |
March 13, 2024 | -65.11% |
March 12, 2024 | -61.90% |
March 11, 2024 | -60.96% |
March 08, 2024 | -63.17% |
March 07, 2024 | -63.08% |
March 06, 2024 | -60.39% |
March 05, 2024 | -63.86% |
March 04, 2024 | -64.21% |
March 01, 2024 | -62.37% |
February 29, 2024 | -61.97% |
February 28, 2024 | -64.92% |
February 27, 2024 | -61.82% |
February 26, 2024 | -57.82% |
February 23, 2024 | -61.30% |
February 22, 2024 | -62.20% |
February 21, 2024 | -56.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.55%
Minimum
Nov 10 2023
127.3%
Maximum
Mar 16 2021
-30.47%
Average
-40.29%
Median
Dec 15 2021
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -15.22% |
Perspective Therapeutics Inc | 176.8% |
Protalix BioTherapeutics Inc | -58.28% |
Electromed Inc | 69.55% |
Armata Pharmaceuticals Inc | 54.84% |